INTERNATIONAL PATENT: REVO-CURES (XIAMEN) PHARMACEUTICAL TECHNOLOGY CO., LTD., 锐康九域（厦门）医药科技有限公司 FILES APPLICATION FOR "FIBROBLAST ACTIVATION PROTEIN-Α-RESPONSIVE HYDROLYSIS-INDUCED CHARGE-REVERSAL POLYMER-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-08-04

GENEVA, Aug. 4 -- REVO-CURES (XIAMEN) PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 2608, No. 26, Hubin North Road, Siming DistrictXiamen, Fujian 361018), 锐康九域（厦门）医药科技有限公司 (中国福建省厦门市思明区湖滨北路26号2608室) filed a patent application (PCT/CN2025/073360) for "FIBROBLAST ACTIVATION PROTEIN-Alpha-RESPONSIVE HYDROLYSIS-INDUCED CHARGE-REVERSAL POLYMER-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF" on Jan 20, 2025. With publication no. WO/2025/157102, the details related to the patent application was published on Jul 3...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: REVO-CURES (XIAMEN) PHARMACEUTICAL TECHNOLOGY CO., LTD., 锐康九域（厦门）医药科技有限公司 FILES APPLICATION FOR "FIBROBLAST ACTIVATION PROTEIN-Α-RESPONSIVE HYDROLYSIS-INDUCED CHARGE-REVERSAL POLYMER-DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF"